TNFRSF: Tumor Necrosis Factor Receptor Superfamily
ND: Not Disclosed
*ADC-1013 is partnered with Janssen Biotech Inc. and developed as JNJ-7107. ALG.APV-527 is based on Alligator’s first generation bispecific antibody, ATOR-1016, and is co-developed with Aptevo Therapeutics